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Abstract: This report describes a patient diagnosed with a cardiac
angiosarcoma. The patient presented with cardiac tamponade. A
pericardiocentesis revealed a bloody effusion, but cytology was
nondiagnostic and a chest computed tomography showed only
mediastinal lymphadenopathy. His pericardial effusion recurred 3
weeks later, at which time he was found to have a large right atrial
mass which proved to be a cardiac angiosarcoma. This case report
underscores the difficulties encountered in the diagnosis of cardiac
angiosarcoma.
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(J Thorac Oncol. 2008;3: 800–802)
Primary cardiac angiosarcoma (PCA) is an extremely raretumor associated with a poor prognosis.1 It presents a big
challenge to clinicians due to the difficulty in diagnosis and
management.2
This case describes a PCA which presented with car-
diac tamponade and recurrent pericardial effusions.
CASE REPORT
A 64-year-old previously healthy male was admitted
for chest pain and dyspnea. He had presented with the same
symptoms 1 week before and was treated for a presumed viral
pericarditis. Upon admission, a chest computed tomography
(CT) showed two prominent mediastinal lymph nodes mea-
suring 16 and 13 mm in diameter and a large pericardial
effusion (Figure 1). Shortly thereafter, he developed hypo-
tension. Transthoracic echocardiogram showed a massive
pericardial effusion with cardiac tamponade. Pericardiocen-
tesis yielded 1.2 liter of bloody pericardial fluid which was
negative for malignancy. Although the etiology of the peri-
cardial effusion remained unknown, the patient rapidly sta-
bilized and he was later discharged. Positron emission tomog-
raphy scan demonstrated a hypermetabolic activity in the
mediastinum with a standard uptake value of 8.0. Three
weeks later, during the course of his evaluation, he was
readmitted for chest pain and dyspnea. A repeat chest CT
scan revealed a mass located along the anterior mediastinum
(Figure 2).
Transthoracic echocardiogram demonstrated a pericar-
dial effusion without signs of tamponade and a 6 to 8 cm right
atrial mass. A transvenous biopsy of the right atrium was
negative for malignancy. Left heart catheterization revealed a
hypervascular tumor that extended from the right coronary
artery ostium to the acute margin of the heart. He underwent
cardiopulmonary bypass surgery with successful resection of
a 9.0  6.5  4.3 cm right atrial mass. The diagnosis of
high-grade angiosarcoma was made on pathology (Figure 3).
Immunohistochemically, the tumor cells were positive for the
endothelial marker CD31 and the intermediate filament vi-
mentin, whereas reactivity to keratin, S100 protein, desmin,
and actin was negative. These findings support the diagnosis
of angiosarcoma.
A staging evaluation done 4 weeks later revealed bilat-
eral pulmonary metastasis. Despite palliative chemotherapy
with paclitaxel, the tumor progressed within 1 month with
recurrent tumor in the right atrium, as well as new brain,
splenic, adrenal, and bone metastasis. Patient succumbed 5
months after diagnosis was made.
DISCUSSION
Primary cardiac tumors are rare, with an incidence of
0.0017% in autopsy series.1 In adults, 25% of primary cardiac
tumors are malignant, 25 to 30% of which are angiosarco-
mas.2 PCAs are two to three times more common in males
than in females and more often involve the right atrium.1,2
PCAs are aggressive tumors, with metastasis found in
66 to 89% of patients at the time of diagnosis. The most
common metastatic sites are the pericardium, lungs, medias-
tinal lymph nodes, and vertebrae.1
The diagnosis of PCA may prove challenging, due to
the often nonspecific nature of its initial presentation. Its
clinical manifestation depends on the tumor location, the
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degree of regional involvement, and the presence or absence
of metastasis.3
Clinically, PCA often mimics right-sided congestive
heart failure, and may exhibit findings, such as vena cava
obstruction, pericardial effusion, tamponade, arrhythmia,
conduction disturbances, and constitutional symptoms.1,2
Echocardiography is usually the first imaging modality
used, the transesophageal technique being the more sensi-
tive.1,4 CT, magnetic resonance, and nuclear imaging add
very important information in the evaluation of PCA.5,6
Transvenous or thoracoscopic cardiac biopsy are useful in the
diagnosis of cardiac angiosarcoma when the tumor is large.7
However, the diagnosis is usually confirmed on thoracotomy
or at autopsy.1
In our patient, the reactivity to CD31, a very specific
marker, and vimentin, a very sensitive marker for angiosar-
coma, confirm the vascular nature of the tumor.
It is important to note that the negative pericardial fluid
cytology in our patient despite the presence of tumor is a
reminder of the limited diagnostic value of this test.8
In additional, the CT scan may fail to detect even large
masses. In our example, the tumor was undetected on the first
CT, possibly due to the large pericardial effusion obscuring
the mass. Hence, a chest CT obtained after pericardiocentesis
would potentially provide better sensitivity.
PCAs generally have a dismal prognosis with a median
survival of approximately 6 months.3 Effective treatment for
PCA has not yet been established. Complete resection of the
tumor is the first treatment of choice.2,3 However, PCAs are
frequently not completely resectable and up to 80% of patients
present with metastasis at time of diagnosis, both leading to a
poor prognosis.2 Cardiac transplantation has been performed in
selected patients and could allow complete resection of the
tumor. Nevertheless, concern remains about enhancing tumor
growth in the setting of immunosuppressive drugs.2
The efficacy of adjuvant chemotherapy and radiotherapy
remains unclear due to the rarity of this tumor and the resulting
lack of large randomized trials.1–3 There are only anecdotal
reports of long-term survival in patients treated with surgery and
adjuvant chemotherapy and/or radiotherapy.4,9
CONCLUSION
This case report highlights the difficulty in diagnosis
and management of this rare entity. The occurrence of he-
mopericardium necessitates close follow-up even with initial
FIGURE 1. Two prominent lymph nodes noted in the ante-
rior mediastinum.
FIGURE 2. A large soft tissue mass seen along the ante-
rior pericardium on chest CT done 3 weeks after his first
presentation.
FIGURE 3. Fusiform atypical cells (arrow) delineate anasto-
mozing vascular space. These findings are characteristic for
angiosarcoma (Hematoxylin-eosin).
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negative investigations, because it could be the first manifes-
tation of cardiac angiosarcoma.3,10
Although optimal treatment has not yet been estab-
lished, an early diagnosis provides an opportunity for more
aggressive treatment with a possibly more favorable out-
come.4,9
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